Global Acute Lymphocytic/Lymphoblastic leukemia Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 65

Global Acute Lymphocytic Leukemia Market 2015-2019

Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market, including Amgen, Bristol-Myers Squibb, and Novartis.

Market landscape of acute lymphocytic leukemia

Acute lymphocytic leukemia or acute lymphoblastic leukemia, is a malignancy of the blood cells that affects the lymphoblasts or leukemic blasts, which witnesses an uncontrolled cell division. The main symptoms a patient exhibits are weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding.

Currently, the disease cannot be cured completely but the risk can be reduced by administering medication.

The market research analysts expect the global acute lymphocytic leukemia market to grow at a steady rate and post a CAGR of over 4% during the forecast period. One of the major factors contributing to the growth of the market is the provision for orphan drugs. For instance, in the US, orphan designation for a drug means incentives like tax credits for qualified clinical testing, exemption from prescription drug user fees unless indicated for additional non-orphan indications, and market exclusivity for seven years.

Segmentation of the acute lymphocytic leukemia market by route of administration

  • Oral
  • Parenteral

Many medications are administered through the oral route to guarantee a systemic effect. The oral route is a sub-division of enteral administration and is considered to be one of the safest and most preferred routes of drug administration.

Geographical segmentation of the acute lymphocytic leukemia market

  • Americas
  • APAC
  • EMEA

With a share of over 49%, the Americas dominated the acute lymphocytic leukemia market, with the US being the major revenue contributor. The Americas is closely followed by the EMEA and the APAC region and the market is expected to follow a similar trend during the forecast period.

Competitive landscape and key vendors

The acute lymphocytic leukemia market is marked by the presence of both global and local drug manufacturers with varied product portfolios containing generic and off- label drugs as well as branded therapies. Besides, the high level of unmet medical need is expected to give a platform to the vendors to develop products to cater to relevant areas and enhance their market shares.

Primary vendors in this market are -

  • Amgen
  • Bristol-Myers Squibb
  • Novartis

Other prominent vendors included in this report are Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global acute lymphocytic leukemia market?
  • What are the key market trends impacting the growth of the global acute lymphocytic leukemia market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global acute lymphocytic leukemia market?
  • What are the market opportunities and threats faced by the vendors in the global acute lymphocytic leukemia market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global acute lymphocytic leukemia market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2016

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides informati......
$1500

PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition

PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition Summary PharmSource's data-rich Trend Report, CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition, has ascertained that 2016 was not a halcyon year for new drug approvals with only 25 NMEs being approved since 2010. Global bio/pharma companies received 22 approvals in 2016 (24% of all NDAs), 10% below their 2011-2015 average. Small commercial companies were responsible for 21 approvals (23% of the total), some 5% above their five-year average. There was a clear difference between outsourcing propensity of NME and Non-NME drugs. Only 13% of NMEs sponsored by global bio/pharma comĀ¬panies were outsourced compared with an average of 28% from 2011-2015. However, the larges......
$2995

Global Surgical Waste Management Market 2017-2021

About Surgical Waste Management Waste that is generated during surgical processes is known as surgical waste. Surgical waste is both hazardous and non-hazardous. Out of the waste generated from surgeries, 85% is non-hazardous and 15% is hazardous. Surgical waste is a huge threat to the environment. Hence, it necessitates proper disposal. Annually, around 250 million surgeries are carried out across the globe, which results in the bulk generation of surgical waste. On average, annually, more than two million tons of surgical waste is being generated. Each day, 5,500 tons of surgical waste is being generated, out of which, approximately 825 tons is hazardous surgical waste. Injections and syringes constitute the bulk of medical waste. Globally, each year, more than 12 billion injections are......
$3500

Global Upper Extremities Market 2017-2021

About Upper Extremities The term "extremity" is generally used to refer to a person's limbs and related parts. Upper extremities include the shoulders, hands, elbows, forearms, wrists, and fingers. Lower extremities consist of the feet, toes, ankles, knees, shins, and thighs. The extremity products are used to treat, repair, replace, or heal extremity injuries such as fractures or damage. These products include external recovery braces, surgical implants, joint replacements, biologics, and external support implants. The analysts forecast global upper extremities market to grow at a CAGR of 6.84% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global upper extremities market for 2017-2021. To calculate the......
$3500

Global Dental Consumables Market 2017-2021

About Dental Consumables Dental consumables are a set of different dental products that are used in individuals to treat dental impairments, for tooth restoration, and in the treatment of associated gingival tissues. Dental consumables are a set of different dental products that are used in dental procedures. Dental implants are the commonly used dental consumables in the tooth restoration procedures. The major causes of tooth loss are tooth decay, gingivitis, injuries, congenital defects, root canal failure, and excessive wear and tear. Osseointegration is a popular procedure adopted by dentists to lock the implant directly into the jawbone. Dental implants are available in different colors and can be customized. The analysts forecast global dental consumables market to grow at a CAGR......
$3500

Global Bone Cement Mixer Devices Market 2017-2021

About Bone Cement Mixer Devices liquid (accelerator) to fill the space between prosthesis and bone deformities. Many new advanced bone cement mixing devices are being developed to decrease the amount of bubble formation and reduce fumes during mixing. The global bone cement mixer devices market is likely to grow at a CAGR of 4.11% during the forecast period. The use of bone cement in interventional procedures such as vertebroplasty and kyphoplasty is on the rise, which will aid the market growth. Increasing prevalence of orthopedic disorders and growing number of orthopedic surgeries also contribute to the market growth. The Americas comprised the majority share of the market in 2016, but APAC is expected to grow at a higher rate during the forecast period. The analysts forecast global......
$3500

Global Micro Guide Catheters Market 2017-2021

About Micro Guide Catheters A micro guide catheter (also known as microcatheter) is a very small single lumen device used on a guidewire to track or help a physician to target a lesion or to cross the lesion. The microcatheter gives mechanical support to the guidewire and enhances its ability to transmit force (pushability and trackability) to the occlusion. The analysts forecast global micro guide catheters market to grow at a CAGR of 8.75% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global micro guide catheters market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of micro guide catheters. The market is divided into the following segments ba......
$3500

Global Chiropractic Care Market 2017-2021

About Chiropractic Care Chiropractic is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. It is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. The analysts forecast global chiropractic care market to grow at a CAGR of 3.67% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global chiropractic care market for 2017-2021. To calculate the market size, the report considers the revenue generated from ......
$3500

Global Angiography Catheters Market 2017-2021

About Angiography Catheters To treat cardiac diseases such as CAD, physicians perform angiography, which requires catheterization to provide diagnostic and therapeutic treatments. Most of the cardiac catheterization procedures involve access through the femoral and radial arteries. Cardiac catheterization through the femoral artery is a traditional procedure, and is preferred by many physicians. However, many physicians are shifting toward radial artery-based catheterization access as traditional procedures have many complications that can even cause death in certain cases. An angioplasty procedure can be performed by widening the narrow blood vessel (plaqued blood vessel). To view and perform the angioplasty procedure, various types of angiography catheters are used. The analysts fore......
$3500

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Pancreatic Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500